Handelsavisen
prelaunch
Companies ›Healthcare ›FTRE.O
FT
FTRE.O — NASDAQ Life Sciences Tools & Services

Ftre.O

$19,32
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
-32,0 %
ROE
-175,0 %
Net margin
-36,2 %
Debt / equity
1,86
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$20,70
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About

Fortrea Holdings Inc operates as a commercial bank within the Financials sector, generating revenue through banking services, though the provided data contains conflicting industry codes suggesting a potential classification error with Life Sciences Tools & Services.

Business. Fortrea Holdings Inc operates as a commercial bank within the Financials sector, generating revenue through banking services, though the provided data contains conflicting industry codes suggesting a potential classification error with Life Sciences Tools & Services.

Classification85 %
SectorHealth Care
Industry groupLife Sciences Tools & Services
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
AQR Capital Management, LLC
largest disclosed fund holder
Profitability→
-175,0 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning FTRE.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,4 %−2,7 %−0,9 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Consumer Staples−0,7 %+2,3 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to FTRE.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Peers
    • DividendDividend USD 1.75/sh2026-09-25 · Bank of America (BAC)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · JPMorgan Chase (JPM)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · Citigroup (C)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressJames French Hill — Fortrea Holdings Inc. - Common2025-06-23 · Republican · AR · Sale · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Fortrea Holdings Inc operates as a commercial bank within the Financials sector, generating revenue through banking services, though the provided data contains conflicting industry codes suggesting a potential classification error with Life Sciences Tools & Services.

    Classification85 %
    SectorHealth Care
    Industry groupLife Sciences Tools & Services
    AI synthesis
    GENERATED
    — missing data
    Key takeaways
    • The company reports a net loss of $986.2 million, resulting in a negative ROE of -1.75 and ROA of -0.36.
    • Debt-to-equity ratio of 1.86 indicates high leverage, with long-term debt of $1.05 billion exceeding cash reserves of $174.6 million.
    • Liquidity risk is medium, driven by negative net cash and significant liability levels relative to equity.
    • Dilution risk is low, with no difference between basic and diluted share counts.
    • Geographic exposure includes subsidiaries in Asia, Latin America, and Europe, suggesting complex regulatory and operational risks.
    • Classification conflicts exist between Banking industry tags and sector classification Health Care codes, warranting further investigation into business activities.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $19,32
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $563.5M
    Net cashⓘ
    -$873.4M
    Current ratioⓘ
    —
    Debt / equityⓘ
    1.9
    ROAⓘ
    -36.3%
    ROEⓘ
    -1.8%
    Cash conversionⓘ
    -12.0%
    CapEx / revenueⓘ
    0.9%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships79 disclosed relationships · 2 types · extracted from filings & disclosures
    Partners1
    Subsidiaries78
    EX21:018af4be6a99EX21:018af4be6a99Subsidiarie97%
    EX21:06492a6edfaaEX21:06492a6edfaaSubsidiarie97%
    EX21:0c25d8e3a366EX21:0c25d8e3a366Subsidiarie97%
    EX21:0dffae062ee1EX21:0dffae062ee1Subsidiarie97%
    EX21:0f8961d3cd8dEX21:0f8961d3cd8dSubsidiarie97%
    EX21:11a02e571939EX21:11a02e571939Subsidiarie97%
    EX21:179aa814db1dEX21:179aa814db1dSubsidiarie97%
    EX21:18a5c8a128aaEX21:18a5c8a128aaSubsidiarie97%
    EX21:20155af988faEX21:20155af988faSubsidiarie97%
    EX21:22a972ab1b01EX21:22a972ab1b01Subsidiarie97%
    EX21:22d8945ed3d7EX21:22d8945ed3d7Subsidiarie97%
    EX21:23429513b3a8EX21:23429513b3a8Subsidiarie97%
    EX21:2489e585a33bEX21:2489e585a33bSubsidiarie97%
    EX21:272cbbb554c7EX21:272cbbb554c7Subsidiarie97%
    EX21:298184b06910EX21:298184b06910Subsidiarie97%
    EX21:2c98edc7998dEX21:2c98edc7998dSubsidiarie97%
    EX21:30fca6a4223aEX21:30fca6a4223aSubsidiarie97%
    EX21:334aad279deeEX21:334aad279deeSubsidiarie97%
    EX21:3ec0c6c9f307EX21:3ec0c6c9f307Subsidiarie97%
    EX21:421915322863EX21:421915322863Subsidiarie97%
    EX21:42569dec464bEX21:42569dec464bSubsidiarie97%
    EX21:4fee27b1991aEX21:4fee27b1991aSubsidiarie97%
    EX21:50f0697a25eaEX21:50f0697a25eaSubsidiarie97%
    EX21:5391afb416f7EX21:5391afb416f7Subsidiarie97%
    EX21:573c5f892bdcEX21:573c5f892bdcSubsidiarie97%
    EX21:576b57dd1eceEX21:576b57dd1eceSubsidiarie97%
    EX21:59276dd8d66cEX21:59276dd8d66cSubsidiarie97%
    EX21:59e394b4e10bEX21:59e394b4e10bSubsidiarie97%
    EX21:629004a4c9c2EX21:629004a4c9c2Subsidiarie97%
    EX21:64a5dfb59a85EX21:64a5dfb59a85Subsidiarie97%
    EX21:671703ae0dbdEX21:671703ae0dbdSubsidiarie97%
    EX21:681d3799801dEX21:681d3799801dSubsidiarie97%
    EX21:6d7fa9a7c7c9EX21:6d7fa9a7c7c9Subsidiarie97%
    EX21:6e9cfbf7f283EX21:6e9cfbf7f283Subsidiarie97%
    EX21:76474ccd494dEX21:76474ccd494dSubsidiarie97%
    EX21:794c8ffc3d41EX21:794c8ffc3d41Subsidiarie97%
    EX21:7edc7ad75415EX21:7edc7ad75415Subsidiarie97%
    EX21:8113584e657bEX21:8113584e657bSubsidiarie97%
    EX21:83b39ded4957EX21:83b39ded4957Subsidiarie97%
    EX21:869c31ed72b8EX21:869c31ed72b8Subsidiarie97%
    EX21:86c4d699f934EX21:86c4d699f934Subsidiarie97%
    EX21:87d35e32bfffEX21:87d35e32bfffSubsidiarie97%
    EX21:8b1f0eeada30EX21:8b1f0eeada30Subsidiarie97%
    EX21:8d443db14309EX21:8d443db14309Subsidiarie97%
    EX21:8dc5e35d3589EX21:8dc5e35d3589Subsidiarie97%
    EX21:9549fe47ffcfEX21:9549fe47ffcfSubsidiarie97%
    EX21:9749c736f8efEX21:9749c736f8efSubsidiarie97%
    EX21:9d28291d4322EX21:9d28291d4322Subsidiarie97%
    EX21:9d5c2c9717abEX21:9d5c2c9717abSubsidiarie97%
    EX21:9dc556707906EX21:9dc556707906Subsidiarie97%
    EX21:a0714389ec14EX21:a0714389ec14Subsidiarie97%
    EX21:a28bdd9b602eEX21:a28bdd9b602eSubsidiarie97%
    EX21:a40815eba8daEX21:a40815eba8daSubsidiarie97%
    EX21:a86a90b1376bEX21:a86a90b1376bSubsidiarie97%
    EX21:aadf72ad7312EX21:aadf72ad7312Subsidiarie97%
    EX21:ae0984ff8fbfEX21:ae0984ff8fbfSubsidiarie97%
    EX21:ae41afa98590EX21:ae41afa98590Subsidiarie97%
    EX21:aebc7e7887b7EX21:aebc7e7887b7Subsidiarie97%
    EX21:affac1776418EX21:affac1776418Subsidiarie97%
    EX21:b234bb314cb3EX21:b234bb314cb3Subsidiarie97%
    EX21:b945786ec837EX21:b945786ec837Subsidiarie97%
    EX21:b9b4dda640adEX21:b9b4dda640adSubsidiarie97%
    EX21:bec125bfbce2EX21:bec125bfbce2Subsidiarie97%
    EX21:c04800997c7bEX21:c04800997c7bSubsidiarie97%
    EX21:c1f15cf07536EX21:c1f15cf07536Subsidiarie97%
    EX21:c6037040f4b0EX21:c6037040f4b0Subsidiarie97%
    EX21:c6742830a8bdEX21:c6742830a8bdSubsidiarie97%
    EX21:d0088a154e50EX21:d0088a154e50Subsidiarie97%
    EX21:d0ce4322521bEX21:d0ce4322521bSubsidiarie97%
    EX21:d24aba8ee146EX21:d24aba8ee146Subsidiarie97%
    EX21:d47f3bdf272dEX21:d47f3bdf272dSubsidiarie97%
    EX21:da9d7fd63b4dEX21:da9d7fd63b4dSubsidiarie97%
    EX21:dbc6fd4be850EX21:dbc6fd4be850Subsidiarie97%
    EX21:eafe776fa961EX21:eafe776fa961Subsidiarie97%
    EX21:f00a4bc1f8c0EX21:f00a4bc1f8c0Subsidiarie97%
    EX21:f958ef4e9488EX21:f958ef4e9488Subsidiarie97%
    EX21:fc175f513a24EX21:fc175f513a24Subsidiarie97%
    EX21:ff5941f06423EX21:ff5941f06423Subsidiarie97%

    Supply chain

    Vendors → FTRE ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSFTREFTREFtre.O79 entitiesLabcorp Holdings IncSoftwareUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution11 analysts
    Strong buy2
    Buy3
    Hold5
    Sell1
    Strong sell0
    12-month price target$17,80 · Median $18,50
    Low $11,00High $21,00
    Operating income · consensus164,7M USD
    EPS surprise
    −46,7 %
    reported vs consensus · miss
    Revenue surprise
    +4,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$11,00
    Mean$17,80
    Median$18,50
    High$21,00
    Spot$19,32
    −7.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-32,0 %Below median
    Net Margin-36,2 %Below median
    ROE-175,0 %Below median
    Capex / Rev0,9 %Above median
    D/E1,86Bottom quartile
    Cash Conv-0,12Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 28 019 sh16 exercises · 13 grants10 insiders
    • Smith David RossDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • Pesicka Edward ADirector · Restricted Stock Unit → Common StockDisposed 38 817exercise · 2026-06-10
    • Smith David RossDirector · Restricted Stock Unit → Common StockDisposed 38 817exercise · 2026-06-10
    • SANDERS MACHELLEDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • SANDERS MACHELLEDirector · Restricted Stock Unit → Common StockDisposed 38 817exercise · 2026-06-10
    • Ray AmritDirector · Restricted Stock Unit → Common StockDisposed 38 817exercise · 2026-06-10
    • Sharbaugh William JDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • Ray AmritDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • Russell Erin LDirector · Restricted Stock Unit → Common StockDisposed 38 817exercise · 2026-06-10
    • Russell Erin LDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • NEUPERT PETER MDirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • Pesicka Edward ADirector · Restricted Stock Unit → Common StockAcquired 12 852grant · 2026-06-10
    • Morais Mark A.Chief Operating Officer · Restricted Stock Unit → Common StockDisposed 11 006exercise · 2026-06-01
    • Mcconnell Jill G.Chief Financial Officer · Restricted Stock Unit → Common StockDisposed 11 006exercise · 2026-06-01
    • NEUPERT PETER MDirector · Restricted Stock Unit → Common StockDisposed 148 536exercise · 2026-05-14
    • Russell Erin LDirector · Restricted Stock Unit → Common StockDisposed 23 946exercise · 2026-03-20
    • Morais Mark A.Chief Operating Officer · Restricted Stock Unit → Common StockDisposed 4 284exercise · 2026-03-13
    • Mcconnell Jill G.Chief Financial Officer · Restricted Stock Unit → Common StockDisposed 4 284exercise · 2026-03-13
    • Parks RobertChief Accounting Officer · Restricted Stock Unit → Common StockDisposed 5 270exercise · 2026-03-09
    • Morais Mark A.Chief Operating Officer · Restricted Stock Unit → Common StockDisposed 13 966exercise · 2026-03-09
    • Mcconnell Jill G.Chief Financial Officer · Restricted Stock Unit → Common StockDisposed 15 283exercise · 2026-03-09
    • Mcconnell Jill G.Chief Financial Officer · Restricted Stock Unit → Common StockAcquired 88 450grant · 2026-03-06
    • Mcconnell Jill G.Chief Financial Officer · Performance Stock Units → Common StockAcquired 66 667grant · 2026-03-06
    • Morais Mark A.Chief Operating Officer · Performance Stock Units → Common StockAcquired 66 667grant · 2026-03-06
    • Morais Mark A.Chief Operating Officer · Restricted Stock Unit → Common StockAcquired 52 030grant · 2026-03-06

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Capex To Revenue
      capital_expenditure / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    Source documents
    • FORTREA HOLDINGS INC. Market data — financials · 2026-07-29
    • reconciler_enqueue (reconciler) on FTRE.O · 2026-07-29
    • FTRE.O HA canonical relationships · 2026-07-29

    Ownership & reference

    Top holders

    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$31M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$76M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$377M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$30M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$15M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$12M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$4M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$144M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$5M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$22M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$39M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$2M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$22M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$9M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$4M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$7M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$5M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$2M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$12M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Leadership

    • Tom H. PikeChairman of the Board, Chief Executive Officer

    Insider activity

    Net selling0 buys · 16 sellsnet -$423K9 insiders · last 365d
    • Smith David RossDirector · Common StockOther 6 598 · 2026-07-20
    • Morais Mark A.Chief Operating Officer · Common StockSold 4 674 @ $16,82$79K · 2026-06-10
    • SANDERS MACHELLEDirector · Common StockOther 38 817 · 2026-06-10
    • Smith David RossDirector · Common StockOther 38 817 · 2026-06-10
    • Smith David RossDirector · Common StockOther 18 244 @ $16,34$298K · 2026-06-10
    • Pesicka Edward ADirector · Common StockOther 38 817 · 2026-06-10
    • Ray AmritDirector · Common StockOther 38 817 · 2026-06-10
    • Russell Erin LDirector · Common StockOther 38 817 · 2026-06-10
    • Morais Mark A.Chief Operating Officer · Common StockSold 4 866 @ $15,49$75K · 2026-06-02
    • Mcconnell Jill G.Chief Financial Officer · Common StockSold 4 866 @ $15,49$75K · 2026-06-02
    • Morais Mark A.Chief Operating Officer · Common StockOther 11 006 · 2026-06-01
    • Mcconnell Jill G.Chief Financial Officer · Common StockOther 11 006 · 2026-06-01
    • Parks RobertChief Accounting Officer · Common StockSold 2 000 @ $13,44$27K · 2026-05-18
    • NEUPERT PETER MDirector · Common StockOther 148 536 · 2026-05-14
    • Russell Erin LDirector · Common StockOther 23 946 · 2026-03-20
    • Morais Mark A.Chief Operating Officer · Common StockSold 1 804 @ $9,22$17K · 2026-03-16
    • Mcconnell Jill G.Chief Financial Officer · Common StockSold 1 804 @ $9,22$17K · 2026-03-16
    • Morais Mark A.Chief Operating Officer · Common StockOther 4 284 · 2026-03-13
    • Mcconnell Jill G.Chief Financial Officer · Common StockOther 4 284 · 2026-03-13
    • Mcconnell Jill G.Chief Financial Officer · Common StockSold 2 531 @ $9,21$23K · 2026-03-10
    • Parks RobertChief Accounting Officer · Common StockSold 963 @ $8,93$9K · 2026-03-10
    • Parks RobertChief Accounting Officer · Common StockSold 964 @ $9,21$9K · 2026-03-10
    • Morais Mark A.Chief Operating Officer · Common StockSold 2 299 @ $8,93$21K · 2026-03-10
    • Morais Mark A.Chief Operating Officer · Common StockSold 2 300 @ $9,21$21K · 2026-03-10
    • Mcconnell Jill G.Chief Financial Officer · Common StockSold 2 530 @ $8,93$23K · 2026-03-10

    Short positioning

    10.3Mshares short+5.0% vs prior
    10.18days to cover
    61.4%short of daily vol
    171fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    FTRE.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    FTREJPMBACCLH.OEX21:018EX21:064EX21:0c2EX21:0dfEX21:0f8EX21:11aLife Sciences
    This companyPeerSectorPartnersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Current liabilities (annual): USD 913.3MUnknown
    • Total liabilities (annual): USD 2.15BUnknown
    • Operating cash flow (annual): USD 113.5MUnknown
    • Net income (annual): USD -989MUnknown
    • Operating income (annual): USD -872.6MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -11Unknown
    • Total assets (annual): USD 2.72BUnknown
    • Current assets (annual): USD 897.2MUnknown
    • Cash & equivalents (annual): USD 174.6MUnknown
    • Shares outstanding (annual): 93.1MUnknown
    • Long-term debt (annual): USD 1.05BUnknown
    • Shareholders' equity (annual): USD 563.5MUnknown
    • EPS (basic) (annual): USD-PER-SHARES -11Unknown
    • Pre-tax income (annual): USD -983MUnknown
    • Revenue (annual): USD 2.72BUnknown
    • Current liabilities (annual): USD 949.5MUnknown
    • Operating income (annual): USD -161.9MUnknown
    • Total liabilities (annual): USD 2.22BUnknown
    • Shares outstanding (annual): 89.7MUnknown
    • Cash & equivalents (annual): USD 118.5MUnknown
    • Total assets (annual): USD 3.58BUnknown
    • Operating cash flow (annual): USD 262.8MUnknown
    • Pre-tax income (annual): USD -275MUnknown
    • EPS (basic) (annual): USD-PER-SHARES -4Unknown
    Showing 24 of 29 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-29 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-20INSIDERSmith David Ross transacted 6.6k sh — Director
    2026-06-12FILING8-K filing →
    2026-06-10 00:00 UTCINSIDER25 insider transactions — 2026-06 · net sell $527k 14 derivative
    2026-06-10 00:00 UTCINSIDER25 insider transactions — 2026-06 · net sell $527k 14 derivative
    2026-06-10INSIDERSmith David Ross transacted 38.8k sh — Director
    2026-06-10INSIDERSmith David Ross transacted 18.2k sh — Director ~$298k
    2026-06-10INSIDERPesicka Edward A transacted 38.8k sh — Director
    2026-06-10INSIDERMorais Mark A. sold 4.7k sh — Chief Operating Officer ~$79k
    2026-06-10INSIDERRussell Erin L transacted 38.8k sh — Director
    2026-06-10INSIDERRay Amrit transacted 38.8k sh — Director
    2026-06-10INSIDERSANDERS MACHELLE transacted 38.8k sh — Director
    2026-06-10INSIDERSANDERS MACHELLE disposed of 38.8k sh Restricted Stock Unit — Director
    2026-06-10INSIDERRay Amrit disposed of 38.8k sh Restricted Stock Unit — Director
    2026-06-10INSIDERSmith David Ross acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERNEUPERT PETER M acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERSANDERS MACHELLE acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERPesicka Edward A acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERPesicka Edward A disposed of 38.8k sh Restricted Stock Unit — Director
    2026-06-10INSIDERRay Amrit acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERSharbaugh William J acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERRussell Erin L disposed of 38.8k sh Restricted Stock Unit — Director
    2026-06-10INSIDERRussell Erin L acquired 12.9k sh Restricted Stock Unit — Director
    2026-06-10INSIDERSmith David Ross disposed of 38.8k sh Restricted Stock Unit — Director
    2026-06-02INSIDERMorais Mark A. sold 4.9k sh — Chief Operating Officer ~$75k
    2026-06-02INSIDERMcconnell Jill G. sold 4.9k sh — Chief Financial Officer ~$75k
    2026-06-01INSIDERMorais Mark A. transacted 11.0k sh — Chief Operating Officer
    2026-06-01INSIDERMcconnell Jill G. transacted 11.0k sh — Chief Financial Officer
    2026-06-01INSIDERMcconnell Jill G. disposed of 11.0k sh Restricted Stock Unit — Chief Financial Officer
    2026-06-01INSIDERMorais Mark A. disposed of 11.0k sh Restricted Stock Unit — Chief Operating Officer
    2026-05-18 00:00 UTCINSIDER3 insider transactions — 2026-05 1 derivative
    2026-05-18 00:00 UTCINSIDER3 insider transactions — 2026-05 1 derivative
    2026-05-18INSIDERParks Robert sold 2.0k sh — Chief Accounting Officer ~$27k
    2026-05-14INSIDERNEUPERT PETER M transacted 148.5k sh — Director
    2026-05-14INSIDERNEUPERT PETER M disposed of 148.5k sh Restricted Stock Unit — Director
    2026-05-05FILING10-Q filing →
    2026-05-05FILING8-K filing →
    2026-04-27FILINGDEF 14A filing →
    2026-03-20 00:00 UTCINSIDER25 insider transactions — 2026-03 · net sell $138k 11 derivative
    Showing the 40 most recent of 63 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage